Sponsor Check › Person
Named as an officer, director or promoter on SEC Form D filings · MA, CA, NH · Jun 23, 2011 → Aug 20, 2019
Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:23 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET
Ben Auspitz is listed as a director on 15 SEC Form D filings by 6 issuers between Jun 2011 and Aug 2026. Largest by amount reported sold: Compass Therapeutics LLC (Cambridge, MA — biotechnology — 2015–2018; $110.2M reported sold to 20 investors), Unum Therapeutics Inc. (Cambridge, MA — biotechnology — 2014–2015; $104.4M reported sold to 22 investors), Checkmate Pharmaceuticals, Inc. (Cambridge, MA — biotechnology — 2017–2019; $85.1M reported sold to 17 investors), Ultragenyx Pharmaceutical Inc. (Novato, CA — biotechnology — 2011–2012; $75M reported sold to 34 investors), Prana Therapies, Inc. (Encinitas, CA — biotechnology — 2026; $40.2M reported sold to 9 investors) and 1 more (all listed below).
What this means A repeat sponsor — 6 separate companies raised money with this person listed as director, over about 15 years. Across those companies the filings report $420.9M sold in total.
Listed alongside Carl L. Gordon (4 shared filings), Charles Yon (4 shared filings), Corey Goodman (4 shared filings), Errik Anderson (4 shared filings), Michael Powell (4 shared filings) and 48 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Ben. Each name links to their own page.
The issuers belong to 2 sponsor groups: Compass Therapeutics (2 issuers, $170.7M reported sold, 2014–2020) and Antlia (2 issuers, $6.56M reported sold, 2020–2026).
What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 15 public filings for Ben Auspitz and found 14 differences, 2 worth asking the sponsor about: Form D filed 258 days after the first sale; Ben Auspitz is no longer listed on the Jan 28, 2020 amendment; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.
Community search for Ben Auspitz has not run yet — it is #11,717 of 37,638 in line; searches run around the clock at the hosts' allowed rate. Searched so far: 641 names.
Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.
Five things investors ask first. Items still in human review are counted, not shown.
None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:23 AM ET.
State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Ben Auspitz..
State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).
None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:23 AM ET.
State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons cover issuers and sponsor groups — see the issuer pages under Deals
14 differences found between the filings for Ben Auspitz — 2 worth asking about (compared 15 filings on Oct 24, 2026)
United States Bankruptcy Court, D. Massachusetts docket "Charles E. Yon" filed Dec 15, 2003, closed Apr 29, 2005. Charles Yon (listed on the same filings) is listed as Debtor ("Charles E. Yon"). Our match estimate: 70%.
What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.
The filing says the first sale was Nov 25, 2025. The Form D was filed Aug 10, 2026 — 258 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 243 days past that.
What this means The notice went in months after money was taken in. Late notices are common and carry no penalty by themselves, but it is fair to ask the sponsor why the paperwork lagged.
The filing says the first sale was Dec 22, 2017. The Form D was filed Jan 8, 2018 — 17 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 2 days past that.
What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.
The filing says the first sale was Oct 3, 2014. The Form D was filed Oct 20, 2014 — 17 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 2 days past that.
What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.
No amendment in the last 12 months on an offering that may still be open — Compass Therapeutics LLC (latest filing Jul 16, 2018) · No amendment in the last 12 months on an offering that may still be open — Compass Therapeutics LLC (latest filing Jan 8, 2018) · No amendment in the last 12 months on an offering that may still be open — Unum Therapeutics Inc. (latest filing Oct 20, 2014) · No amendment in the last 12 months on an offering that may still be open — Ultragenyx Pharmaceutical Inc. (latest filing Jul 30, 2012) · No amendment in the last 12 months on an offering that may still be open — Ultragenyx Pharmaceutical Inc. (latest filing Jun 23, 2011)
What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.
Ben Auspitz appears on the Aug 20, 2019 Form D (director) but not on the Jan 28, 2020 Form D/A for the same offering.
What this means People leave, and the issuer must list only current officers, directors and promoters. It is still worth asking why this person left and who replaced them.
The Jul 1, 2015 filing says $120,977,535 offered; the Sep 21, 2016 Form D/A says $170,205,999.
What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.
"Other Health Care" (Oct 20, 2014); then "Biotechnology" (Jun 25, 2015).
What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.
This page covers filings where the address state is MA or CA or NH. A separate record, "Ben Auspitz" with address state NJ or NY or MD, is listed on 5 filings — most recently by Zero Point Five Therapeutics, Inc. (Apr 17, 2025). The two records do not overlap in time: this page runs Jun 23, 2011 to Aug 20, 2019; the other runs Jul 12, 2023 to Apr 17, 2025.
What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.
This page covers filings where the address state is MA or CA or NH. A separate record, "Ben Auspitz" with address state MO, is listed on 1 filing — most recently by Indalo Therapeutics, Inc. (Aug 1, 2017). Both records have filings in the same period (Aug 1, 2017).
What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.
This page covers filings where the address state is MA or CA or NH. A separate record, "BEN AUSPITZ" with address state NC, is listed on 1 filing — most recently by PRECISION BIOSCIENCES INC (May 12, 2015). Both records have filings in the same period (May 12, 2015).
What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.
This page covers filings where the address state is MA or CA or NH. A separate record, "Ben Auspitz" with address state MT or D0, is listed on 5 filings — most recently by LigoCyte Pharmaceuticals Inc (Jun 28, 2012). The two records do not overlap in time: this page runs Jun 23, 2011 to Aug 20, 2019; the other runs Aug 14, 2009 to Jun 21, 2011.
What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.
The people listed on the Jul 1, 2015 filing give Hanover, NH; on the Sep 21, 2016 filing they give Cambridge, MA. The address now on file (245 First Street, Cambridge, MA) is a registered-agent or shared-office address used by 7 issuers.
What this means A registered agent's address is a mailbox, not where the team works. Ask where the business actually operates.
MA on 11 filings (Jun 23, 2011 to Aug 20, 2019); CA on 3 filings (Dec 31, 2012 to Aug 10, 2026); NH on 1 filing (Jul 1, 2015).
What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.
What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.
1 of 12 offerings reports sales commissions totalling $937,500; 0 report finder's fees; 1 reports proceeds to related persons totalling $1,710,000. (includes amounts the issuer reported as estimates)
| Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it | Source |
|---|---|---|---|---|---|
| Aug 10, 2026 D Prana Therapies, Inc. File 021-593683 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jun 5, 2026 D Antlia Bioscience, Inc. File 021-586295 | $0 | $0 | $0 The gross proceeds of the offering will be used for operating expenses, working capital and other general corporate purposes. | None listed on this filing | EDGAR ↗ |
| Aug 20, 2019 D Checkmate Pharmaceuticals, Inc. File 021-347004 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Apr 1, 2019 D/A Checkmate Pharmaceuticals, Inc. File 021-327684 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jul 16, 2018 D/A Compass Therapeutics LLC File 021-242888 | $0 | $0 | $1,710,000 (est.) | None listed on this filing | EDGAR ↗ |
| Jan 8, 2018 D Compass Therapeutics LLC File 021-302629 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jun 16, 2017 D Checkmate Pharmaceuticals, Inc. File 021-288881 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jun 25, 2015 D Unum Therapeutics Inc. File 021-242431 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Oct 20, 2014 D Unum Therapeutics Inc. File 021-226748 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Dec 31, 2012 D Ultragenyx Pharmaceutical Inc. File 021-189181 | $937,500 | $0 | $0 | COWEN AND COMPANY BrokerCheck CRD 7616 ↗ | EDGAR ↗ |
| Jul 30, 2012 D Ultragenyx Pharmaceutical Inc. File 021-181946 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jun 23, 2011 D Ultragenyx Pharmaceutical Inc. File 021-161694 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
Every issuer that named Ben Auspitz on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.
Raised $40.2M from 9 investors (100% of the $40.2M target) as of the latest filing. Ben is listed as director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $6M from 10 investors (30% of the $20M target) as of the latest filing. Ben is listed as director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $85.1M from 17 investors (100% of the $16M target) as of the latest filing. Ben is listed as director on 4 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $110.2M from 20 investors (65% of the $170.2M target) as of the latest filing. Ben is listed as director on 4 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $104.4M from 22 investors (100% of the $65M target) as of the latest filing. Ben is listed as director on 2 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $75M from 34 investors (100% of the $75M target) as of the latest filing. Ben is listed as director on 3 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.
Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.
Carl L. Gordon is on 62 issuers in total — a repeat sponsor. Their page lists every one.
Corey Goodman is on 21 issuers in total — a repeat sponsor. Their page lists every one.
Philip Ferneau is on 13 issuers in total — a repeat sponsor. Their page lists every one.
Errik Anderson is on 17 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Ben Auspitz. Their page shows their other deals.
Bruce Booth is on 21 issuers in total — a repeat sponsor. Their page lists every one.
Stephen Squinto is on 16 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Ben Auspitz. Their page shows their other deals.
Alexis Borisy is on 16 issuers in total — a repeat sponsor. Their page lists every one.
Martin A. Taylor is on 23 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Ben Auspitz. Their page shows their other deals.
Listed on the same filings as Ben Auspitz. Their page shows their other deals.
Listed on the same filings as Ben Auspitz. Their page shows their other deals.
Listed on the same filings as Ben Auspitz. Their page shows their other deals.
Listed on the same filings as Ben Auspitz. Their page shows their other deals.
One team, 2 deal companies. Ben Auspitz is listed on 1 of them.
Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Ben Auspitz.
One team, 2 deal companies. Ben Auspitz is listed on 1 of them.
Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Ben Auspitz.
A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.
Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).
None of the 6 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.
Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.
Property records are matched to companies only, never to individuals, so none are matched to Ben Auspitz by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 6 issuers this person is listed on — nothing matched.
Websites and social links of the issuers Ben Auspitz is listed on: none on file. No website or social profile named in Prana Therapies, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #13,469 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓
One-tap searches on sites we do not index ourselves, with the name pre-filled (Encinitas, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when Ben Auspitz appears on a new Form D, or when a court case or SEC action is matched to them. See plans →